Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
25.31
-0.34 (-1.33%)
Nov 6, 2026, 4:00 PM EST - Market closed
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year. That makes Neurogene the 29,727th largest employer in the world and 3,776th in the United States.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$848,168
Market Cap
506.49M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Valneva SE | 620 |
| REGENXBIO | 371 |
| Capricor Therapeutics | 231 |
| DiaMedica Therapeutics | 35 |
| Monopar Therapeutics | 22 |
| Indaptus Therapeutics | 5 |
NGNE News
- 3 days ago - Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 days ago - Neurogene to Participate in Upcoming Investor Conferences - Business Wire
- 12 days ago - Neurogene presents new data on NGN-401 gene therapy at ESGCT 2026 - TheFly
- 12 days ago - Neurogene Presents New Data at ESGCT Congress that Reinforce Key Differentiators of NGN-401 Gene Therapy for Rett Syndrome - Business Wire
- 19 days ago - Neurogene Announces Upcoming Presentations Highlighting Key Differentiators of NGN-401 for Rett Syndrome at the ESGCT 33rd Annual Congress - Business Wire
- 4 weeks ago - Neurogene initiated with an Overweight at JPMorgan - TheFly
- 4 weeks ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Neurogene Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts